Sino Biopharmaceutical Stock (OTC: SBMFF)

Sino Biopharmaceutical Stock (OTC:SBMFF), Trade Ideas

Sino Biopharmaceutical Co, or SBP, is one of the largest drugmakers in China, with CNY 27 billion revenue in 2021. Its four most important therapeutic areas are oncology, hepatitis, cardio-cerebral, and respiratory medicines. SBP's current portfolio is mostly generics, and some key drugs are facing severe price reductions. However, it also has a rich pipeline of early-to-market generics and biosimilars, especially in oncology and respiratory treatments.

Asia

News

Penny Stocks

Markets

General

AAGIY

BABA

CICHY

HNSPF

MPNGY

PNGAY

SBMFF

TCEHY

TSLA

WXXWY

XPEV

NIKE

Hong Kong stocks rallied Friday as the week closed out higher for consumer stocks and EV makers which investors hope will be the beneficiary of a forthcoming government stimulus.  

The Hang Seng Index ended the day 2.1% higher at 17,398.73 while China’s CSI 300 Index rose 1.4% to 3,562.39.

Strong Consumer Turnout Drives Hong Kong Stocks Higher Friday As China&#39;s Former Premier Li Keqiang Dies At 68

Intraday Update

Movers

Trading Ideas

ACKRF

ATUS

AVIFY

BEVVF

BURL

CBLK

CDLX

CLKFF

CLTY

CPRX

CRHKY

DANOY

DKMR

DNACF

New Oriental Education & Technology Group

EMLAF

EPRT

GBBT

GLDLF

GNRC

HEBT

HEI-A

HEMA

HLNE

IDRSF

IMKTA

JBSS

KLAC

KNSL

LAUR

LDOS

LOOP

MAIFF

MEDP

MORN

NSRGF

Nestle Sponsored representing Registered Shares Series B

NSRGY

NXTC

PCTI

Citigourp Global Markets 2% Protected Notes Linked To The Djia

PDRDF

PDRDY

PFSI

RDUS

SHWGY

SSDOY

SSVFF

TCBIP

TERP

TNAV

TORXF

TSGTF

TSPG

WINSTON GOLD MINING ORD by Winston Gold Mining Corp.

WGMCF

XNGSY

XPEL

JMTM

ATBYF

GLGDF

KOOYF

PMMTF

GPPRF

FLMZF

Stocks That Hit 52-Week Highs On Thursday

Biotech

ACAD

ANAB

CELG

GILD

SGMO

4 Biotech Stocks Ready To Crush The Market In 2018

SINO BIOPHARM ORD by Sino Biopharmaceutical Ltd.

Sino Biopharmaceutical Ltd

Week In Review: Betta Pharma Enters $392 Million Deal For C4 Therapeutics' NSCLC Drug

Week In Review: Billion Dollar Deals - Moderna's Shanghai Investment And F-Star's Takeda Collaboration

Sino Biopharmaceutical (SBMFF – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Rebecca Lian...

Hold Rating for Sino Biopharmaceutical: Fair Valuation and Future Risks in Gx Drugs and Pipeline

In a report released yesterday, Chris Lui from Jefferies maintained a Buy rating on Sino Biopharmaceutical (SBMFF – Research Report), with a price ...

Sino Biopharmaceutical (SBMFF) Gets a Buy from Jefferies

Jefferies analyst Chris Lui maintained a Buy rating on Sino Biopharmaceutical (SBMFF – Research Report) yesterday and set a price target of HK$9.20...

Jefferies Keeps Their Buy Rating on Sino Biopharmaceutical (SBMFF)

In a report released on January 1, Chris Lui from Jefferies maintained a Buy rating on Sino Biopharmaceutical (SBMFF – Research Report), with a pri...